Roche's Webcast Replay on Gazyva in lupus nephritis presented at ASN/ACR 2019

Roche has hosted a live audio webcast and conference call on Tuesday, 12 November 2019.


  • Welcome
    Karl Mahler, Head of Investor Relations
  • Roche in immunology – overview
    Mark Eisner, Global Head of Product Development – Immunology, Infectious Disease & Ophthalmology
  • Phase II Nobility data - efficacy and safety of obinutuzumab or placebo in combination with mycophenolate mofetil in patients with Lupus Nephritis
    Larry Tsai, Global Head of Rheumatology & Respiratory Development
  • Q&A

Please register to access the webcast

* Mandatory


The registration form for the webcast is not available.


Please come back 30 minutes before the webcast start date and fill in the registration form.